Objective -To determine current policies, resources, and attitudes to community growth screening in the United Kingdom. Methods -A postal survey of community paediatricians and paediatric endocrinologists.
The change in the early 1990s towards an increased general practice base for child health surveillance has led many community paediatricians to formulate growth surveillance policies in order to give guidance to health workers in primary care. The Hall report, Health for All Children,l gave some guidelines for growth screening policies, though these were the subject of some criticism at the time.
A further impetus towards a more critical evaluation of screening has been the separation of the National Health Service administration into purchasers and providers of health care, and the greater demand that medicine should be evidence based and give value for money. This is particularly the case for new screening programmes. For these reasons it seemed appropriate in 1994 to undertake a survey of the current state of community growth screening in the United Kingdom.
Methods
A postal survey of all known community paediatricians and members of the British Society for Paediatric Endocrinology was undertaken in the middle of 1994 with repeat questionnaires being sent to non-respondents, followed by telephone contact. One hundred and sixty four paediatricians replied, of whom 84 (51%) were consultant community paediatricians, 35 (21 %) were senior clinical medical officers or clinical medical officers, 31 (19%) were consultant paediatricians, and 6 (4%) were paediatric endocrinologists. The remaining 8 (5%) were other personnel, including child health computing system managers.
In addition to questions about community screening, we also asked about the total adult and childhood population served, to which 143 replied with an estimated total adult population of 39 388 000. By extrapolation from the known population of the United Kingdom it is likely that the survey represents the state of screening for between 68 and 78% of the population. Replies came from as far apart as Orkney and the Channel Islands and covered rural, suburban, and inner city populations. Whereas community paediatric staff represented 72% of the respondents, many of the consultant paediatricians who replied had dual acute and community responsibilities. A number of paediatric endocrinologists did not respond because they felt they had specialist rather than community responsibilities.
The results were analysed using Epi-Info version 5.01b (Public domain software for epidemiology and disease surveillance, Center for Disease Control, Atlanta, Georgia, USA -July 1991). they were available. Twenty six protocols were received and, in practice, these written policies were very variable. Preschool height screening was undertaken by 75% of respondents. Figure  1 shows the ages at which screening took place. The commonest ages for screening were 6 weeks and 3 years, in accordance with the recommendations of the Hall report, Health for All Children. 1 Most commonly, preschool children were measured once (49%) or twice (26%). Height screening at school age was the policy of 81 % of trusts or districts. School entry screening was the most popular option, and once again the great majority of children (74 %) were only measured once (fig 2) .
Seventy six per cent of districts had a standard piece of equipment for community height screening, the most popular being the Minimetre (Raven Equipment Ltd) followed by the Microtoise. A number of respondents were planning to equip with the Leicester measurer (Child Growth Foundation). Clearly, much out of date, poor quality equipment was still in use. In particular, several comments were made about the difficulty of using the Microtoise. A wide variety of growth charts were being used, and many trusts or districts were using more than one type of chart. These charts were based on three different standards: the Tanner-Whitehouse 1975 standards," WHO/Nottingham standards, and the new 1994 standards." Twenty three per cent were using decimal charts. Most policies used more than one referral criterion. Eighty eight (54%) used "less than the third centile", 67 (41%) used "less than -3SD", and 113 (69%) used some form of velocity criterion. A number also used weight criteria, and 10 paid attention to height! weight discrepancies. A number of comments were made on referral criteria, including some doubts about the significance of the results in children whose growth crosses centile lines. Figure 3 shows where children were referred to, the commonest option being the hospital general outpatient clinic. Eight centres had a visiting growth specialist.
Respondents, when asked, felt growth screening was valuable; most (95.5%) felt that it was either extremely valuable or useful if there were adequate resources. A large number of comments were made, including the need for national policies, guidelines, or consensus statements. A small number felt that screening was either a waste of time and resources or that it was likely to detect few children or that its value was not proved after the age of 5. Several replied that it was better thought of as "growth surveillance" rather than screening. Others felt that a more selective approach might be appropriate -for example, in child protection cases or areas where there was a high prevalence of deprivation.
In undertaking this survey we also asked for data about the manpower resources available to paediatriciansthat is, the numbers of school nurses, clinical medical officers, and health visitors. Provision was found to be extremely variable when related to the childhood population. Most (96%), however, had access to the child health computing system. 
Results
One hundred and thirty three (81 %) had a written growth policy. This was often incorporated within a child health surveillance policy, and we asked for copies to be sent if 
Discussion
Any postal survey has a risk of selection bias. It is possible that enthusiasts for growth screening are more likely to respond than sceptics. However, the majority who felt that growth screening was valuable was so large that it is likely that this represents a consensus of opinion among community paediatricians. The study showed very considerable divergence in policy, equipment, and charts. The optimum ages and frequency of measurement need to be established, referral criteria clarified by research and audit, and growth monitoring integrated into a systematic programme of child health surveillance.
The variable provision of manpower re-Hulse, Schilg sources for growth screening is an important factor to be taken into consideration. The child health computing system is a resource that is underused at present and could be used to alert paediatricians to children who are growing inadequately according to predetermined criteria entered on the computing system. Those criteria are as yet not fully determined. 
